Published in Int J Clin Exp Med on May 15, 2015
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 25.54
Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw (2006) 7.19
Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes (1994) 4.66
Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc (2001) 2.54
The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology (2011) 2.15
The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res (1986) 1.72
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood (2011) 1.63
Liver fatty acid-binding protein and obesity. J Nutr Biochem (2010) 1.59
Clinical targeting of the TNF and TNFR superfamilies. Nat Rev Drug Discov (2013) 1.53
Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediators Inflamm (2014) 1.35
Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med (2013) 1.35
Salivary biomarkers: toward future clinical and diagnostic utilities. Clin Microbiol Rev (2013) 1.34
Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. Chem Biol Interact (2011) 1.21
The RGM/DRAGON family of BMP co-receptors. Cytokine Growth Factor Rev (2009) 1.21
Salivary biomarkers for detection of systemic diseases. PLoS One (2013) 1.13
In vitro platforms for evaluating liver toxicity. Exp Biol Med (Maywood) (2014) 1.11
Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population. PLoS One (2013) 1.01
Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis. Front Pharmacol (2014) 1.00
Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity. J Lipid Res (2009) 0.99
Liver fatty acid-binding protein as a sensitive serum marker of acute hepatocellular damage in liver transplant recipients. Clin Chem (2002) 0.95
Impact of antidepressants on cytokine production of depressed patients in vitro. Toxins (Basel) (2013) 0.94
Susceptibility of L-FABP-/- mice to oxidative stress in early-stage alcoholic liver. J Lipid Res (2013) 0.91
Iron-dependent regulation of hepcidin in Hjv-/- mice: evidence that hemojuvelin is dispensable for sensing body iron levels. PLoS One (2014) 0.89
Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.88
A novel validated enzyme-linked immunosorbent assay to quantify soluble hemojuvelin in mouse serum. Haematologica (2012) 0.88
Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Curr Psychiatry Rep (2012) 0.88
Saliva-based biosensors: noninvasive monitoring tool for clinical diagnostics. Biomed Res Int (2014) 0.85
Drug-induced hepatotoxicity: metabolic, genetic and immunological basis. Int J Mol Sci (2014) 0.85
Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy. J Manag Care Pharm (2014) 0.82
Tumour necrosis factor alpha downregulates human hemojuvelin expression via a novel response element within its promoter. J Biomed Sci (2012) 0.82
Proteomic analysis and molecular modelling characterize the iron-regulatory protein haemojuvelin/repulsive guidance molecule c. Biochem J (2013) 0.81
Hepatoprotective role of liver fatty acid binding protein in acetaminophen induced toxicity. BMC Gastroenterol (2014) 0.81
Hepatocellular tumors: immunohistochemical analyses for classification and prognostication. Chin J Cancer Res (2011) 0.80
Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: preclinical and clinical efficacy. Pharmacol Rep (2013) 0.80
Pharmacokinetics of mirtazapine and its main metabolites after single intravenous and oral administrations in rats at two dose rates. Daru (2014) 0.79
Saliva as a non-invasive diagnostic tool for inflammation and insulin-resistance. World J Diabetes (2014) 0.79
Conserved proximal promoter elements control repulsive guidance molecule c/hemojuvelin (Hfe2) gene transcription in skeletal muscle. Genomics (2010) 0.79
When to start aripiprazole therapy in patients with bipolar mania. Neuropsychiatr Dis Treat (2014) 0.79
Glucometabolic hormones and cardiovascular risk markers in antipsychotic-treated patients. J Clin Psychiatry (2014) 0.78
Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy. CNS Spectr (2014) 0.78
Effect of combination of aripiprazole with carbamazepine and fluvoxamine on liver functions in experimental animals. Indian J Pharmacol (2013) 0.77